An isolated insular stroke mimics a bout of overt hepatic encephalopathy in a patient with cirrhosis
Mangini C, Gagliardi R, Causin F, Angeli P, Montagnese S J Hepatol No abstract available Full text
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study
Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Gabriel M, Ehrenbauer AF, Bloom PP, Ripoll C, Sultanik P, Galle PR, Labenz J, Thabut D, Zipprich A, Lok AS, Weissenborn K, Marquardt JU, Lauridsen MM, Nardelli S, Montagnese S, Labenz C Am J Gastroenterol Introduction: The prevalence of minimal hepatic encephalopathy (MHE), in […]
Prognosis and Survival Modelling in Cirrhosis Using Parenclitic Networks
Zhang H, Oyelade T, Moore KP, Montagnese S, Mani AR Front Netw Physiol Background: Liver cirrhosis involves multiple organ systems and has a high mortality. A network approach to complex diseases often reveals the collective system behaviours and intrinsic interactions between organ systems. However, mapping the functional connectivity for each individual patient has been challenging due […]
Circadian rhythms and the liver
Costa R, Mangini C, Domenie E, Zarantonello L, Montagnese S Liver Int This narrative review briefly describes the mammalian circadian timing system, the specific features of the liver clock, also by comparison with other peripheral clocks, the role of the liver clock in the preparation to food intake, and its relationship with energy metabolism. It […]
Hyperammonaemia disrupts daily rhythms reversibly by elevating glutamate in the central circadian pacemaker
Granados-Fuentes D, Cho K, Patti GJ, Costa R, Herzog E D, Montagnese S Liver Int Patients with cirrhosis exhibit features of circadian disruption. Hyperammonaemia has been suggested to impair both homeostatic and circadian sleep regulation. Here, we tested if hyperammonaemia directly disrupts circadian rhythm generation in the central pacemaker, the suprachiasmatic nuclei (SCN) of the […]
Hepatic encephalopathy
Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H Nat Rev Dis Primers Illustrated summary of the article Full text
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
Montagnese S, Gómez MR, Larsen FS, Shawcross D, Thabut D, Vilstrup HA V, Weissenborn K, Rautou PE, Corresponding author: European Association for the Study of the Liver (EASL) Journal of Hepatology The EASL Clinical Practice Guidelines (CPGs) on the management of hepatic encephalopathy (HE) present evidence-based answers to a set of relevant questions (where possible, […]
Evolution of hepatic encephalopathy over time: ecological data from a tertiary referral centre for hepatology
Mangini C, Zarantonello L, Formentin C, Giusti G, Angeli P, Montagnese S Digestive and Liver Disease Objectives Few data on hepatic encephalopathy (HE) over time are available, thus our aim was to study its evolution in patients with varying degree of HE on first assessment. Methods Eighty-six patients with cirrhosis (age = 58 ± 11 […]
New Therapies of Liver Diseases: Hepatic Encephalopathy
Mangini C, Montagnese S J Clin Med Hepatic encephalopathy (HE) is a common complication of advanced liver disease which has profound implications in terms of the patients’ ability to fulfil their family and social roles, to drive and to provide for themselves. Recurrent and persistent HE is still a serious management challenge, translating into a […]
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: a web-based survey
Ponziani FR, Aghemo A, Cabibbo G, Masarone M, Montagnese S, Petta S, Russo FP, Lai Q; AISF COVID-19 survey group Liver International Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has severely limited the clinical activity of most hospitals around the world. A previous survey of the Italian Association for the Study of the Liver (AISF) […]